Oxford Cannabinoid Technologies Holdings (FRA:0CB) FCF Margin % : 0.00% (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Oxford Cannabinoid Technologies Holdings's Free Cash Flow for the six months ended in Oct. 2023 was €-1.34 Mil. Oxford Cannabinoid Technologies Holdings's Revenue for the six months ended in Oct. 2023 was €0.00 Mil. Therefore, Oxford Cannabinoid Technologies Holdings's FCF Margin % for the quarter that ended in Oct. 2023 was 0.00%.

As of today, Oxford Cannabinoid Technologies Holdings's current FCF Yield % is -217.88%.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's FCF Margin % or its related term are showing as below:

FRA:0CB's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -145.04
* Ranked among companies with meaningful FCF Margin % only.

Oxford Cannabinoid Technologies Holdings FCF Margin % Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings FCF Margin % Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

FCF Margin %

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
FCF Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's FCF Margin %

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Cannabinoid Technologies Holdings's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's FCF Margin % falls into.

Oxford Cannabinoid Technologies Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Oxford Cannabinoid Technologies Holdings's FCF Margin for the fiscal year that ended in Apr. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Apr. 2023 )	/	Revenue (A: Apr. 2023 )
	=	-7.8	/	0
	=	%

Oxford Cannabinoid Technologies Holdings's FCF Margin for the quarter that ended in Oct. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Oct. 2023 )	/	Revenue (Q: Oct. 2023 )
	=	-1.341	/	0
	=	%

Oxford Cannabinoid Technologies Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OCTP:UK

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines